Speed your small molecule analysis with Optimer. Rapid development, rapid assays, rapid results. Download this datapack to learn how: success in discovery for small molecule ligand is increased with the…
The accurate and sensitive detection of small molecules in point-of-care and in situ biosensor assays could enable faster and simpler analysis to extend diagnostic capabilities. The Optimer platform incorporates…
Working with affinity tools that offer the highest batch consistency is critical for the development of robust assays and reliable data. Optimer binders deliver the best batch-to-batch consistency for…
Speeding project timelines can be vital to the development of any life science product. Optimer offers an antibody alternative that can cut as much 75% (2.8 years) off the…
Novel biosensor diagnostics can improve patient outcomes and reduce healthcare costs. Download our application note to discover how our partner, QSM Diagnostics, is integrating Optimer technology into its rapid diagnostic…
The COVID-19 pandemic has presented significant challenges to the biopharmaceutical industry, requiring rapid discovery and development of affinity reagents targeting SARS-CoV-2 for research, diagnostics and therapeutics. The long development…
